Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Algernon Pharmaceuticals Inc Class A (AGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.160 +0.005    +3.23%
31/05 - Closed. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 21,500
  • Bid/Ask: 0.150 / 0.160
  • Day's Range: 0.160 - 0.160
Algernon Pharma 0.160 +0.005 +3.23%

AGN Candlestick Patterns

 
Dozens of bullish and bearish live candlestick chart patterns for the Algernon Pharmaceuticals Inc Class A stock and use them to predict future market behavior. The Algernon Pharma stock patterns are available in a variety of time frames for both long and short term investments. Gain a trading edge with the auto pattern recognition feature and gain an insight into what the patterns mean.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customize

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 1W Current
Completed Patterns
Bullish doji Star 1D 2 May 29, 2024
Dragonfly Doji 1D 2 May 29, 2024
Harami Bullish 1D 2 May 29, 2024
Harami Cross 1D 2 May 29, 2024
Three Outside Down 1D 3 May 28, 2024
Belt Hold Bearish 1D 4 May 27, 2024
Engulfing Bearish 1D 4 May 27, 2024
Harami Bullish 1D 5 May 24, 2024
Harami Cross 1D 5 May 24, 2024
Belt Hold Bearish 1D 6 May 23, 2024
Harami Cross 5H 6 May 28, 2024 12:00PM
Harami Bullish 5H 6 May 28, 2024 12:00PM
Tri-Star Bullish 1H 6 May 29, 2024 03:00PM
Separating Lines Bullish 1D 7 May 22, 2024
Bullish doji Star 5H 8 May 27, 2024 11:00AM
Tri-Star Bullish 30 8 May 29, 2024 03:30PM
Belt Hold Bearish 5H 9 May 27, 2024 06:00AM
Tri-Star Bearish 30 9 May 29, 2024 10:30AM
Tri-Star Bullish 15 9 May 29, 2024 03:45PM
Harami Cross 1M 10 Jul 23
Harami Cross Bearish 1W 10 Mar 17, 2024
Engulfing Bearish 5H 10 May 24, 2024 01:00PM
Tri-Star Bearish 15 10 May 29, 2024 10:30AM
Three Outside Up 1W 11 Mar 10, 2024
Belt Hold Bearish 1D 11 May 15, 2024
Belt Hold Bearish 1D 12 May 14, 2024
Dark Cloud Cover 1D 12 May 14, 2024
Harami Bullish 5H 12 May 23, 2024 12:00PM
Harami Cross 5H 12 May 23, 2024 12:00PM
Tri-Star Bullish 1H 12 May 28, 2024 09:00AM
Bullish doji Star 30 12 May 28, 2024 11:30AM
Harami Bullish 30 12 May 28, 2024 11:30AM
Harami Cross 30 12 May 28, 2024 11:30AM
Upside Gap Three Methods 5H 13 May 23, 2024 07:00AM
Engulfing Bearish 5H 13 May 23, 2024 07:00AM
Belt Hold Bearish 5H 13 May 23, 2024 07:00AM
Three Outside Down 30 13 May 28, 2024 11:00AM
Tri-Star Bearish 1H 14 May 27, 2024 10:00AM
Belt Hold Bearish 30 14 May 28, 2024 10:30AM
Engulfing Bearish 30 14 May 28, 2024 10:30AM
Bullish Engulfing 1W 15 Feb 11, 2024
Three Inside Up 5H 15 May 22, 2024 06:00AM
Belt Hold Bearish 1D 16 May 08, 2024
Harami Bullish 5H 16 May 21, 2024 03:00PM
Harami Cross 5H 16 May 21, 2024 03:00PM
Harami Cross 15 16 May 28, 2024 11:15AM
Harami Bullish 15 16 May 28, 2024 11:15AM
Bullish doji Star 15 16 May 28, 2024 11:15AM
Abandoned Baby Bullish 1W 17 Jan 28, 2024
Bullish Engulfing 1W 17 Jan 28, 2024
Morning Doji Star 1W 17 Jan 28, 2024
Morning Star 1W 17 Jan 28, 2024
Three Inside Up 1W 17 Jan 28, 2024
Tri-Star Bullish 30 17 May 28, 2024 09:00AM
On Neck Bearish 1W 18 Jan 21, 2024
Harami Bullish 1W 18 Jan 21, 2024
Harami Cross 1W 18 Jan 21, 2024
Three Inside Up 1D 18 May 06, 2024
Belt Hold Bullish 1H 18 May 24, 2024 01:00PM
Bullish Engulfing 1H 18 May 24, 2024 01:00PM
Tri-Star Bearish 15 18 May 28, 2024 10:45AM
Falling Three Methods 1M 19 Oct 22
Harami Bullish 1D 19 May 03, 2024
Harami Cross 1D 19 May 03, 2024
Dark Cloud Cover 1M 20 Sep 22
Harami Cross Bearish 1W 20 Jan 07, 2024
Bullish Engulfing 1M 21 Aug 22
Separating Lines Bullish 1W 21 Dec 31, 2023
Homing Pigeon 1D 21 May 01, 2024
Tri-Star Bullish 30 21 May 24, 2024 03:30PM
Tri-Star Bearish 5H 22 May 15, 2024 02:00PM
Tri-Star Bearish 1H 23 May 23, 2024 01:00PM
Harami Cross Bearish 30 23 May 24, 2024 01:30PM
Tri-Star Bullish 15 23 May 28, 2024 09:15AM
Belt Hold Bearish 1D 25 Apr 24, 2024
Belt Hold Bearish 5H 25 May 14, 2024 08:00AM
Dark Cloud Cover 5H 25 May 14, 2024 08:00AM
Tri-Star Bearish 15 25 May 27, 2024 10:00AM
Belt Hold Bearish 1H 26 May 23, 2024 09:00AM
Bullish Engulfing 1W 27 Nov 19, 2023
Tri-Star Bullish 1D 27 Apr 22, 2024
Tri-Star Bullish 15 27 May 24, 2024 03:45PM
Bullish Engulfing 1M 28 Jan 22
Doji Star Bearish 1H 29 May 22, 2024 11:00AM
Harami Cross Bearish 15 29 May 24, 2024 01:30PM
Bullish Hammer 1W 30 Oct 29, 2023
Belt Hold Bullish 15 30 May 24, 2024 01:15PM
Bullish Engulfing 15 30 May 24, 2024 01:15PM
Bullish doji Star 1D 31 Apr 10, 2024
Harami Bullish 5H 31 May 08, 2024 12:00PM
Harami Cross 5H 31 May 08, 2024 12:00PM
Belt Hold Bearish 5H 32 May 08, 2024 07:00AM
Harami Bullish 1H 32 May 21, 2024 01:00PM
Harami Cross 1H 32 May 21, 2024 01:00PM
Belt Hold Bearish 1D 33 Apr 05, 2024
Engulfing Bearish 1D 33 Apr 05, 2024
Harami Cross 5H 33 May 07, 2024 11:00AM
Bullish doji Star 5H 33 May 07, 2024 11:00AM
Harami Bullish 5H 33 May 07, 2024 11:00AM
Belt Hold Bearish 30 33 May 23, 2024 09:30AM
Engulfing Bearish 30 33 May 23, 2024 09:30AM
Belt Hold Bearish 5H 35 May 06, 2024 03:00PM
Belt Hold Bearish 30 35 May 22, 2024 03:30PM
Tri-Star Bullish 15 35 May 23, 2024 02:00PM
Tri-Star Bearish 1H 36 May 17, 2024 03:00PM
Tri-Star Bearish 15 36 May 23, 2024 01:15PM
Falling Three Methods 1M 37 Apr 21
Inverted Hammer 1W 38 Sep 03, 2023
Tri-Star Bearish 30 38 May 22, 2024 02:00PM
Three Inside Up 1M 39 Feb 21
Three Outside Up 1D 39 Mar 27, 2024
Harami Bullish 5H 39 May 02, 2024 06:00AM
Harami Cross 5H 39 May 02, 2024 06:00AM
Harami Bullish 1M 40 Jan 21
Harami Cross 1M 40 Jan 21
Belt Hold Bullish 1D 40 Mar 26, 2024
Bullish Engulfing 1D 40 Mar 26, 2024
Engulfing Bearish 1M 41 Dec 20
Downside Gap Three Methods 1W 41 Aug 13, 2023
Tri-Star Bearish 1H 41 May 15, 2024 03:00PM
Tri-Star Bearish 5H 42 Apr 29, 2024 08:00AM
Harami Bullish 1H 43 May 14, 2024 03:00PM
Harami Cross 1H 43 May 14, 2024 03:00PM
Bullish doji Star 30 43 May 21, 2024 01:30PM
Harami Bullish 30 43 May 21, 2024 01:30PM
Harami Cross 30 43 May 21, 2024 01:30PM
Belt Hold Bearish 15 43 May 22, 2024 03:45PM
Doji Star Bearish 1D 44 Mar 15, 2024
Belt Hold Bearish 1H 44 May 14, 2024 12:00PM
Falling Three Methods 1W 45 Jul 16, 2023
Tri-Star Bullish 15 45 May 22, 2024 02:45PM
Doji Star Bearish 30 46 May 21, 2024 10:00AM
Tri-Star Bearish 15 46 May 22, 2024 02:15PM
Belt Hold Bearish 5H 47 Apr 24, 2024 08:00AM
Tri-Star Bullish 30 49 May 17, 2024 03:30PM
Harami Bullish 1W 50 Jun 11, 2023
Harami Cross 1W 50 Jun 11, 2023
Tri-Star Bullish 5H 50 Apr 19, 2024 01:00PM
Tri-Star Bullish 1H 50 May 10, 2024 09:00AM
Tri-Star Bearish 30 50 May 17, 2024 03:00PM
Doji Star Bearish 15 50 May 22, 2024 10:00AM
Inverted Hammer 1M 53 Dec 19
Harami Cross 15 53 May 21, 2024 01:45PM
Bullish doji Star 15 53 May 21, 2024 01:45PM
Harami Bullish 15 53 May 21, 2024 01:45PM
Bullish doji Star 5H 54 Apr 10, 2024 09:00AM
Harami Bullish 1H 54 May 08, 2024 02:00PM
Harami Cross 1H 54 May 08, 2024 02:00PM
Belt Hold Bearish 1H 55 May 08, 2024 09:00AM
Tri-Star Bearish 30 55 May 15, 2024 03:00PM
Tri-Star Bearish 15 55 May 21, 2024 10:30AM
Tri-Star Bearish 5H 56 Apr 05, 2024 02:00PM
Bullish doji Star 1H 56 May 07, 2024 03:00PM
Harami Bullish 1H 56 May 07, 2024 03:00PM
Harami Cross 1H 56 May 07, 2024 03:00PM
Harami Bullish 30 58 May 14, 2024 03:30PM
Harami Cross 30 58 May 14, 2024 03:30PM
Belt Hold Bearish 1H 59 May 06, 2024 03:00PM
Belt Hold Bearish 30 59 May 14, 2024 12:00PM
Harami Bullish 1D 60 Feb 09, 2024
Harami Cross 1D 60 Feb 09, 2024
Harami Cross 1M 61 Apr 19
Homing Pigeon 1D 61 Feb 08, 2024
Belt Hold Bullish 5H 61 Apr 02, 2024 06:00AM
Bullish Engulfing 5H 61 Apr 02, 2024 06:00AM
Tri-Star Bearish 30 61 May 13, 2024 12:30PM
Tri-Star Bearish 15 61 May 17, 2024 03:00PM
Three Outside Down 1W 62 Mar 19, 2023
Abandoned Baby Bearish 1W 63 Mar 12, 2023
Engulfing Bearish 1W 63 Mar 12, 2023
Evening Doji Star 1W 63 Mar 12, 2023
Upside Gap Three Methods 1W 63 Mar 12, 2023
Harami Bullish 1H 63 May 02, 2024 09:00AM
Harami Cross 1H 63 May 02, 2024 09:00AM
Doji Star Bearish 1W 64 Mar 05, 2023
Gravestone Doji 1W 64 Mar 05, 2023
Harami Bullish 1D 64 Feb 02, 2024
Harami Cross 1D 64 Feb 02, 2024
Harami Bullish 5H 64 Apr 01, 2024 05:00AM
Harami Cross 5H 64 Apr 01, 2024 05:00AM
Belt Hold Bearish 1D 65 Feb 01, 2024
Tri-Star Bullish 30 65 May 10, 2024 09:00AM
Tri-Star Bullish 15 65 May 16, 2024 02:15PM
Belt Hold Bearish 1D 66 Jan 31, 2024
Tri-Star Bearish 1D 67 Jan 29, 2024
Tri-Star Bearish 15 67 May 15, 2024 03:15PM
Inverted Hammer 1W 68 Feb 05, 2023
Doji Star Bearish 1D 69 Jan 24, 2024
Tri-Star Bullish 5H 69 Mar 26, 2024 02:00PM
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AGN Comments

Write your thoughts about Algernon Pharmaceuticals Inc Class A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Powell
Mike Powell May 26, 2023 2:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Significant progress has been made in their drug development while they've also secured additional funding. Recent news of Notice of Allowance from USPTO and successful rights offering only further validate their business model of repurposing drugs and protecting IP.
Mike Powell
Mike Powell Apr 21, 2023 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Recent news that AGN's received notice of allowance for NP-251 (Repirinast) as a promising candidate treating CKD and fatty liver disease is pretty interesting, adding another strong candidate in treating chronic diseases with unmet needs. Furthermore, preclinical studies are showing its a strong candidate for treatment.
Mike Powell
Mike Powell Apr 13, 2023 1:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Latest results from the phase 1 study of DMT for stroke patients is making solid progress with results from their 2nd cohort successfully dosed without any issues - 3rd cohort is receiving higher doses with the purpose of determining if hitting "Sigma 1" receptor with DMT can create enough brain derived neurotrophic factor to aid in healing process for stroke patients.
Harrison Joel
Harrison Joel Apr 06, 2023 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good to hear that they've dosed the 2nd round of patients in the DMT Phase 1 trial. With nearly 800,000 people each year experiencing a stroke in the US alone, this provides a huge market opportunity and can be a life-changing form of treatment for many. So definitely keep tabs on development as research continues on the treatment.
Harrison Joel
Harrison Joel Feb 16, 2023 2:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DMT for stoke has been found safe to proceed to the next phase, now they're focusing on identifying the correct dosage amount for the best recovery effect. DMT could be a revolutionary drug in the space and could further legitimize psychedelics in healthcare as a whole.
Mike Powell
Mike Powell Jan 24, 2023 3:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Algernon announces they’ve dosed the first subject in the Phase 1 DMT clinical stroke study. This study is being conducted at the Centre for Human Drug Research in Leiden, Netherlands. The first part of this study will use a single-escalating dose design aimed at identifying a safe and tolerable dose that will not produce psychedelic effects. AGN’s DMT trial also positions them as one of the cheapest psychedelic stocks on the market
Harrison Joel
Harrison Joel Jan 18, 2023 2:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The DMT study makes AGN the first company to begin investigating its effects on stroke! Will be interesting to see the results as they continue with phase 1 and move into phase 2 later on.
Mike Powell
Mike Powell Jan 13, 2023 2:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The appointment of Dr. Peter Dicpinigaitis MD as a medical consultant to Algernon Pharmaceuticals' chronic cough research program is pretty significant. Dr. Dicpinigaitis is the founder and director of the Montefiore Cough Center, one of the few specialty centers in the world exclusively committed to the evaluation and management of patients with chronic cough. He’s authored many peer-reviewed journal articles and book chapters on cough and is considered an authority on the performance of cough challenge studies in clinical research. He also serves as the Editor-in-Chief of the journal LUNG. His expertise will be valuable to the company as they advance towards their upcoming Phase 2b chronic cough study of NP-120 (Ifenprodil).
Mike Powell
Mike Powell Jan 12, 2023 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is Ifenprodil the next billion dollar cough drug? Algernon Pharmaceuticals recently received FDA Orphan Drug Designation for Ifenprodil in IPF treatment & CEO Christopher Moreau shares an update for a new Phase 2B study slated to commence in July 2023 which will determine if its superior to current cough treatments.
Mike Powell
Mike Powell Dec 06, 2022 1:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Catalyst alert with Algernon’s recent news that they’ve been granted orphan drug designation by the FDA for its use of Ifenprodil as a treatment for IPF. FDA orphan drug designation is massive due to the potential 7-year exclusivity following approval. Prices have climbed ~22%+ on the day of this news, more to come as they progress through the next steps of their clinical program.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email